Donna-Michelle Smith

1.7k total citations
12 papers, 363 citations indexed

About

Donna-Michelle Smith is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Donna-Michelle Smith has authored 12 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Cancer Research and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Donna-Michelle Smith's work include Cancer, Hypoxia, and Metabolism (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and MRI in cancer diagnosis (3 papers). Donna-Michelle Smith is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and MRI in cancer diagnosis (3 papers). Donna-Michelle Smith collaborates with scholars based in United Kingdom, Germany and United States. Donna-Michelle Smith's co-authors include Matthew Squires, Nicola G. Wallis, Ruth E. Feltell, Neil T. Thompson, David M. Cross, Edward J. Lewis, John F. Lyons, Hilary Calvert, Daruka Mahadevan and D. Von Hoff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Donna-Michelle Smith

11 papers receiving 351 citations

Peers

Countries citing papers authored by Donna-Michelle Smith

Since Specialization

Citations

This map shows the geographic impact of Donna-Michelle Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna-Michelle Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna-Michelle Smith more than expected).

Fields of papers citing papers by Donna-Michelle Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna-Michelle Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna-Michelle Smith. The network helps show where Donna-Michelle Smith may publish in the future.

Co-authorship network of co-authors of Donna-Michelle Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Donna-Michelle Smith. A scholar is included among the top collaborators of Donna-Michelle Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna-Michelle Smith. Donna-Michelle Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: A translational neuroimaging study 2025 ·Journal of Psychopharmacology ·Eilidh MacNicol, Michelle Kokkinou, Maria Elisa Serrano Navacerrada, Donna-Michelle Smith, Jennifer Li, Camilla Simmons, Eugene Kim, (unknown), (unknown), (unknown), (unknown), (unknown), Volker Knappertz, Benjamin J. Whalley, Andrew C. McCreary, Steven Williams, David Virley, Diana Cash	0
2	Thymidine Metabolism as a Confounding Factor for 3′-Deoxy-3′-¹⁸F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model 2018 ·Journal of Nuclear Medicine ·Sonja Schelhaas, (unknown), Sven Hermann, Natascha Rieder, (unknown), Kathrin Heinzmann, Davina J. Honess, Donna-Michelle Smith, (unknown), Nathalie Just, Sabrina Doblas, Ralph Sinkus, (unknown), (unknown), John R. Griffiths, Cornelius Faber, Richard Schneider, Eric O. Aboagye, Andréas H. Jacobs	4
3	Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using ¹⁸F-ICMT-11 and ¹⁸F-FLT PET 2018 ·Journal of Nuclear Medicine ·Kathrin Heinzmann, Quang‐Dé Nguyen, Davina J. Honess, Donna-Michelle Smith, Stephen M. Stribbling, (unknown), Chris Barnes, John R. Griffiths, Eric O. Aboagye	8
4	3′-Deoxy-3′-[18F]Fluorothymidine Uptake Is Related to Thymidine Phosphorylase Expression in Various Experimental Tumor Models 2017 ·Molecular Imaging and Biology ·Sonja Schelhaas, Kathrin Heinzmann, Davina J. Honess, Donna-Michelle Smith, (unknown), Sandra Heskamp, Timothy H. Witney, Laurent Besret, Sabrina Doblas, John R. Griffiths, Eric O. Aboagye, Andréas H. Jacobs	5
5	Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer 2016 ·Cancer Research ·Sonja Schelhaas, (unknown), (unknown), Sven Hermann, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, John R. Griffiths, Cornelius Faber, Andréas H. Jacobs	13
6	A phase I trial of the ɣ-secretase inhibitor (GSI) MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma (PDAC). 2014 ·Journal of Clinical Oncology ·Natalie Cook, Bristi Basu, Donna-Michelle Smith, Aarthi Gopinathan, (unknown), William P. Steward, Thorsten Hagemann, Balaji Venugopal, David A. Tuveson, (unknown), David Alan Anthoney, Hayley Farmer, Helen Turner, (unknown), Sarah Halford, Duncan I. Jodrell	9
7	Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging 2014 ·Journal of Nuclear Medicine ·Sonja Schelhaas, (unknown), Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael Kuhlmann, Carsten Müller‐Tidow, Klaus Kopka, Otmar Schober, Michael Schäfers, Richard Schneider, Eric O. Aboagye, John R. Griffiths, Cornelius Faber, Andréas H. Jacobs	19
8	A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy 2011 ·Cancer Chemotherapy and Pharmacology ·Tashinga E. Bapiro, Frances M. Richards, Mae A. Goldgraben, Kenneth P. Olive, Basetti Madhu, Kristopher K. Frese, Natalie Cook, Michael A. Jacobetz, Donna-Michelle Smith, David A. Tuveson, John R. Griffiths, Duncan I. Jodrell	47
9	A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors 2011 ·Annals of Oncology ·Daruka Mahadevan, Ruth Plummer, Matthew Squires, (unknown), Sandra Kurtin, (unknown), Tomislav Dragovich, Joëlla W. Adams, Victoria Lock, Donna-Michelle Smith, D. Von Hoff, Hilary Calvert	73
10	Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines 2009 ·Molecular Cancer Therapeutics ·Matthew Squires, Ruth E. Feltell, Nicola G. Wallis, Edward J. Lewis, Donna-Michelle Smith, David M. Cross, John F. Lyons, Neil T. Thompson	134
11	A dose-escalation and pharmacodynamic study of AT9283 in patients with refractory solid tumours 2008 ·Journal of Clinical Oncology ·Elizabeth Ruth Plummer, Hilary Calvert, Hendrik-Tobias Arkenau, Kirsty Mallett, Matthew Squires, Donna-Michelle Smith, Samuel E. Lewis, I. Judson	12
12	Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator 2007 ·Journal of Medicinal Chemistry ·Martyn Frederickson, Owen Callaghan, Gianni Chessari, Miles Congreve, (unknown), (unknown), Rachel McMenamin, Donna-Michelle Smith, M. Vinković, Nicola G. Wallis	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact